Lv0
0 积分 2024-12-12 加入
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
18小时前
已完结
Implementation of digital health technology in clinical trials: the 6R framework
3个月前
已完结
Threshold of toxicological concern (TTC) for developmental and reproductive toxicity of anticancer compounds
3个月前
已完结
Estimation of toxic hazard—A decision tree approach
3个月前
已完结
Thresholds of Toxicological Concern Based on Structure-Activity Relationships
3个月前
已完结
皖公网安备34019202002308
